Transaction in Own Shares

Summary by AI BETAClose X

International Biotechnology Trust PLC announced on July 24, 2026, that it purchased 50,000 of its ordinary shares at 1,080 pence each, which will be held in treasury. Following this transaction, the Company's issued share capital stands at 41,383,817 ordinary shares, with 9,730,983 shares held in treasury, resulting in a total of 31,652,834 voting rights. This updated figure serves as the denominator for shareholders to determine their notification obligations under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Disclaimer*

UK 100

Latest directors dealings